387 related articles for article (PubMed ID: 17493268)
21. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
23. Cytostatic and cytocidal effects of mistletoe (Viscum album L.) quercus extract Iscador.
Kovacs E; Link S; Toffol-Schmidt U
Arzneimittelforschung; 2006 Jun; 56(6A):467-73. PubMed ID: 16927528
[TBL] [Abstract][Full Text] [Related]
24. Lack of an antitumoral effect of immunomodulatory galactoside-specific mistletoe lectin on N-methyl-N-nitrosourea-induced urinary bladder carcinogenesis in rats.
Kunze E; Schulz H; Ahrens H; Gabius HJ
Exp Toxicol Pathol; 1997 Aug; 49(3-4):167-80. PubMed ID: 9314050
[TBL] [Abstract][Full Text] [Related]
25. A novel triterpene extract from mistletoe induces rapid apoptosis in murine B16.F10 melanoma cells.
Strüh CM; Jäger S; Schempp CM; Scheffler A; Martin SF
Phytother Res; 2012 Oct; 26(10):1507-12. PubMed ID: 22318938
[TBL] [Abstract][Full Text] [Related]
26. Assessment of extracts from mistletoe (Viscum album) for herb-drug interaction by inhibition and induction of cytochrome P450 activities.
Doehmer J; Eisenbraun J
Phytother Res; 2012 Jan; 26(1):11-7. PubMed ID: 21538623
[TBL] [Abstract][Full Text] [Related]
27. Mistletoe lectin transport by M-cells in follicle-associated epithelium (FAE) and IL-12 secretion in dendritic cells situated below FAE in vitro.
Lyu SY; Park WB
Arch Pharm Res; 2010 Sep; 33(9):1433-41. PubMed ID: 20945143
[TBL] [Abstract][Full Text] [Related]
28. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
Gorter RW; van Wely M; Reif M; Stoss M
Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines.
Klingbeil MF; Xavier FC; Sardinha LR; Severino P; Mathor MB; Rodrigues RV; Pinto DS
Oncol Rep; 2013 Nov; 30(5):2316-22. PubMed ID: 24026291
[TBL] [Abstract][Full Text] [Related]
30. Preliminary antiproliferative effects of some species of Terminalia, Combretum and Pteleopsis collected in Tanzania on some human cancer cell lines.
Fyhrquist P; Mwasumbi L; Vuorela P; Vuorela H; Hiltunen R; Murphy C; Adlercreutz H
Fitoterapia; 2006 Jul; 77(5):358-66. PubMed ID: 16797142
[TBL] [Abstract][Full Text] [Related]
31. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
Kelter G; Fiebig HH
Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
[TBL] [Abstract][Full Text] [Related]
32. Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells.
Mulsow K; Enzlein T; Delebinski C; Jaeger S; Seifert G; Melzig MF
PLoS One; 2016; 11(4):e0153825. PubMed ID: 27088729
[TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis of endothelial cells by Viscum album: a role for anti-tumoral properties of mistletoe lectins.
Duong Van Huyen JP; Bayry J; Delignat S; Gaston AT; Michel O; Bruneval P; Kazatchkine MD; Nicoletti A; Kaveri SV
Mol Med; 2002 Oct; 8(10):600-6. PubMed ID: 12477970
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro.
Seifert G; Jesse P; Laengler A; Reindl T; Lüth M; Lobitz S; Henze G; Prokop A; Lode HN
Cancer Lett; 2008 Jun; 264(2):218-28. PubMed ID: 18314258
[TBL] [Abstract][Full Text] [Related]
35. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
Gardin NE
Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
[TBL] [Abstract][Full Text] [Related]
36. Variable sensitivity of lymphoblastoid cells to apoptosis induced by Viscum album Qu FrF, a therapeutic preparation of mistletoe lectin.
Duong Van Huyen JP; Sooryanarayana ; Delignat S; Bloch MF; Kazatchkine MD; Kaveri SV
Chemotherapy; 2001; 47(5):366-76. PubMed ID: 11561140
[TBL] [Abstract][Full Text] [Related]
37. Effects of Korean mistletoe lectin (Viscum album coloratum) on proliferation and cytokine expression in human peripheral blood mononuclear cells and T-lymphocytes.
Lyu SY; Park WB
Arch Pharm Res; 2007 Oct; 30(10):1252-64. PubMed ID: 18038904
[TBL] [Abstract][Full Text] [Related]
38. Generation of reactive oxygen intermediates (ROI) by the thionins from Viscum album L.
Büssing A; Schaller G; Pfüller U
Anticancer Res; 1998; 18(6A):4291-6. PubMed ID: 9891480
[TBL] [Abstract][Full Text] [Related]
39. Mistletoe lectin-I augments antiproliferative effects of the PPARgamma agonist rosiglitazone on human malignant melanoma cells.
Freudlsperger C; Dahl A; Hoffmann J; Reinert S; Schumacher U
Phytother Res; 2010 Sep; 24(9):1354-8. PubMed ID: 20812278
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma.
Duong Van Huyen JP; Delignat S; Bayry J; Kazatchkine MD; Bruneval P; Nicoletti A; Kaveri SV
Cancer Lett; 2006 Nov; 243(1):32-7. PubMed ID: 16412563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
